Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 9.01M | $45.5M | $5.05 | Jun 17, 2021 | Indirect |
Therapeutics Acquisition Corp. | Chief Executive Officer, Director | Common Stock | 1.1M | $13.7M | $12.45 | Jun 29, 2021 | Indirect |
Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 2.75K | $13.9K | $5.05 | Jun 17, 2021 | Direct |
Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 8.38K | Jun 17, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PNT | Therapeutics Acquisition Corp. | Jun 29, 2021 | 1 | $2.09M | 4 | Jun 30, 2021 | Chief Executive Officer, Director |
PNT | Therapeutics Acquisition Corp. | Jun 24, 2021 | 1 | $8.89M | 4 | Jun 24, 2021 | Chief Executive Officer, Director |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director, 10%+ Owner |